What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Cancer
Prakash S. Nagarkatti mainly investigates Immunology, Immune system, Cancer research, Apoptosis and Inflammation.
Prakash S. Nagarkatti interconnects Receptor and Cytotoxic T cell in the investigation of issues within Immunology.
As a part of the same scientific study, Prakash S. Nagarkatti usually deals with the Immune system, concentrating on Cannabinoid receptor and frequently concerns with Cannabinoid and Endocannabinoid system.
His studies in Cancer research integrate themes in fields like Bryostatin, Aryl hydrocarbon receptor, Latent Virus and Rottlerin.
His Apoptosis research integrates issues from Internal medicine, In vitro, Endocrinology and Cell biology.
The various areas that Prakash S. Nagarkatti examines in his Inflammation study include Colitis and Resveratrol.
His most cited work include:
- Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease (241 citations)
- Cannabinoids as novel anti-inflammatory drugs (233 citations)
- Role of cytokines as a double-edged sword in sepsis. (225 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Immunology, Immune system, Inflammation, Cancer research and Internal medicine.
The Immunology study combines topics in areas such as Cytotoxic T cell and Pharmacology.
As part of the same scientific family, Prakash S. Nagarkatti usually focuses on Immune system, concentrating on Cannabinoid receptor and intersecting with Endocannabinoid system.
Prakash S. Nagarkatti works mostly in the field of Inflammation, limiting it down to topics relating to Colitis and, in certain cases, Ulcerative colitis, Inflammatory bowel disease and Colorectal cancer.
He studied Cancer research and microRNA that intersect with Gene expression and Epigenetics.
His Internal medicine course of study focuses on Endocrinology and Apoptosis, CD8, Toxicity and Thymocyte.
He most often published in these fields:
- Immunology (42.22%)
- Immune system (23.75%)
- Inflammation (23.48%)
What were the highlights of his more recent work (between 2017-2021)?
- Inflammation (23.48%)
- Cancer research (22.96%)
- Immune system (23.75%)
In recent papers he was focusing on the following fields of study:
Prakash S. Nagarkatti focuses on Inflammation, Cancer research, Immune system, FOXP3 and Pharmacology.
His Inflammation research incorporates elements of Cytokine, Downregulation and upregulation, Colitis and Inflammatory bowel disease.
His studies deal with areas such as T cell, Apoptosis, microRNA, Myeloid-derived Suppressor Cell and Resveratrol as well as Cancer research.
His study with Immune system involves better knowledge in Immunology.
His study in Immunology is interdisciplinary in nature, drawing from both Microbiome and ARDS.
Prakash S. Nagarkatti usually deals with FOXP3 and limits it to topics linked to Aryl hydrocarbon receptor and Cell biology and Carcinogen.
Between 2017 and 2021, his most popular works were:
- Macrophage depletion using clodronate liposomes decreases tumorigenesis and alters gut microbiota in the AOM/DSS mouse model of colon cancer (46 citations)
- Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells (41 citations)
- Resveratrol modulates the gut microbiota to prevent murine colitis development through induction of Tregs and suppression of Th17 cells. (38 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Cancer
His scientific interests lie mostly in Inflammation, Cancer research, Gut flora, Immune system and Immunology.
Prakash S. Nagarkatti has included themes like Downregulation and upregulation, Colitis, Cytokine and Resveratrol in his Inflammation study.
He combines subjects such as Apoptosis and FOXP3 with his study of Resveratrol.
His Cancer research study combines topics from a wide range of disciplines, such as T cell, Aryl hydrocarbon receptor, Chemokine, Transforming growth factor beta and Effector.
His research integrates issues of Gene expression profiling, Peripheral blood mononuclear cell, Interleukin, Regulation of gene expression and Epigenetics in his study of Immune system.
Prakash S. Nagarkatti is involved in the study of Immunology that focuses on Multiple sclerosis in particular.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
